The S&P 500 has been hovering around the all-time high currently. Solid U.S. economic data points, easy monetary and fiscal policies and vaccine distribution led to this upsurge. The index is up 19.7% this year and 30.6% past year.
In the last 10 years, the SPDR S&P 500 (SPY) ETF gained a 15.23% compound annual return, with a 13.45% standard deviation. Tech stocks were mainly responsible for the S&P 500’s monumental achievement.
The S&P 500 currently puts 27.80% of the fund in Information Technology. Apple (6.17%), Microsoft (5.99%) and Amazon (3.66%) are its top three holdings. About 26.54% of the fund is held in the top-10 section, out of which more than 20% goes to Information Technology.
For the 466 S&P 500 members that have reported Q2 results already this reporting season, total earnings are up 97.8% on 25.8% higher revenues, with 86.9% beating EPS estimates and 86.9% topping revenue estimates, per Zacks Earnings Trends issued on Aug 18, 2021.
The healthcare sector holds 13.73% of the fund. The sector is defensive in nature. Amid the ongoing health emergency, no one can ignore the necessity of this sector, let alone the sector’s durability amid the growing need for medication and treatments for other critical diseases.
In particular, renewed optimism over the global economic recovery after the first full U.S. approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech bolstered risk-on trade. This is because the full approval will help mitigate the ongoing surge in the COVID-19 Delta variant and lead to a continued reopening of the economy.
Hence, investors can play S&P 500 ETFs like SPY, Vanguard S&P 500 ETF (VOO - Free Report) , iShares Core S&P 500 ETF (IVV - Free Report) , S&P 500 growth ETF (SPYG - Free Report) , S&P 500 value ETF (SPYV - Free Report) , SPDR Portfolio S&P 500 High Dividend ETF Fund (SPYD) and leveraged S&P 500 ETFs like Direxion Daily S&P 500 Bull 3X Shares (SPXL), ProShares Ultra S&P500 (SSO) and ProShares UltraPro S&P500 (UPRO - Free Report) .
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
The S&P 500 has been hovering around the all-time high currently. Solid U.S. economic data points, easy monetary and fiscal policies and vaccine distribution led to this upsurge. The index is up 19.7% this year and 30.6% past year.
In the last 10 years, the SPDR S&P 500 (SPY) ETF gained a 15.23% compound annual return, with a 13.45% standard deviation. Tech stocks were mainly responsible for the S&P 500’s monumental achievement.
The S&P 500 currently puts 27.80% of the fund in Information Technology. Apple (6.17%), Microsoft (5.99%) and Amazon (3.66%) are its top three holdings. About 26.54% of the fund is held in the top-10 section, out of which more than 20% goes to Information Technology.
For the 466 S&P 500 members that have reported Q2 results already this reporting season, total earnings are up 97.8% on 25.8% higher revenues, with 86.9% beating EPS estimates and 86.9% topping revenue estimates, per Zacks Earnings Trends issued on Aug 18, 2021.
The healthcare sector holds 13.73% of the fund. The sector is defensive in nature. Amid the ongoing health emergency, no one can ignore the necessity of this sector, let alone the sector’s durability amid the growing need for medication and treatments for other critical diseases.
In particular, renewed optimism over the global economic recovery after the first full U.S. approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech bolstered risk-on trade. This is because the full approval will help mitigate the ongoing surge in the COVID-19 Delta variant and lead to a continued reopening of the economy.
Hence, investors can play S&P 500 ETFs like SPY, Vanguard S&P 500 ETF (VOO - Free Report) , iShares Core S&P 500 ETF (IVV - Free Report) , S&P 500 growth ETF (SPYG - Free Report) , S&P 500 value ETF (SPYV - Free Report) , SPDR Portfolio S&P 500 High Dividend ETF Fund (SPYD) and leveraged S&P 500 ETFs like Direxion Daily S&P 500 Bull 3X Shares (SPXL), ProShares Ultra S&P500 (SSO) and ProShares UltraPro S&P500 (UPRO - Free Report) .
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on UPRO - FREE
Get the latest research report on VOO - FREE
Get the latest research report on IVV - FREE
Get the latest research report on SPYG - FREE
Get the latest research report on SPYV - FREE